Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 7, 2006

ES Cell-Qualified Growth Media and Supplements Alliance Inked

  • Mediatech and GlobalStem formed a strategic alliance to develop, manufacture, validate, and distribute embryonic stem cell-qualified growth media and supplements.

    The goal of this alliance is to fill the need among stem cell researchers for fully characterized stem cell lines, validated feeder cells, qualified reagents, and characterization tools.

    Mediatech reports that it has over 20 years of cGMP experience in the manufacture of sterile solutions, while GlobalStem will bring its experience in the research of embryonic stem cells to the relationship.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »